Zymeworks (ZYME) Stock Up 29% in Three Months: Here's Why
Zymeworks (ZYME) recently entered a collaboration with Jazz Pharmaceuticals (JAZZ) for its lead pipeline candidate. This has been a significant catalyst for the stock.
Mesa Labs and Eldorado Gold have been highlighted as Zacks Bull and Bear of the Day
Mesa Labs and Eldorado Gold are part of the Zacks Bull and Bear of the Day article.
Sanofi's (SNY) Dupixent & Vaccines Make the Stock Attractive
One can invest in Sanofi (SNY) due to the strong performance of Dupixent, above-market sales growth of the Consumer unit, consistent pipeline innovation and regular accretive collaboration deals.
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying
We present three small biotech stocks, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2023 despite an uncertain macro environment.